Clinical microbiology and infection, 2004-07, Vol.10 (7), p.665-667
2004
Details
- Autor(en) / Beteiligte
- Titel
- Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993–2001
- Ist Teil von
- Clinical microbiology and infection, 2004-07, Vol.10 (7), p.665-667
- Ort / Verlag
- Oxford, UK: Elsevier Ltd
- Erscheinungsjahr
- 2004
- Link zum Volltext
- Quelle
- Wiley-Blackwell Full Collection
- Beschreibungen/Notizen
- Between January 1993 and December 2001, the overall frequency of resistance to third-generation cephalosporins in isolates of Enterobacteriaceae from Charles Nicolle Hospital, Tunis, rose from 2.4% to 7.4%. Klebsiella pneumoniae was the most prevalent species (56%), followed by Escherichia coli (15%) and Proteus mirabilis (9%). A rate of 49% was observed among isolates from paediatric patients in 1999, caused mostly by outbreaks in the neonatal intensive care unit of K. pneumoniae and P. mirabilis isolates that produced extendedspectrum β-lactamases.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1198-743XeISSN: 1469-0691DOI: 10.1111/j.1469-0691.2004.00959.xTitel-ID: cdi_proquest_miscellaneous_66644870
- Format
- –
- Schlagworte
- Anti-Bacterial Agents - pharmacology, Antibacterial agents, Antibiotics. Antiinfectious agents. Antiparasitic agents, beta-Lactam Resistance, beta-Lactamases - metabolism, Biological and medical sciences, Cephalosporins - pharmacology, Disease Outbreaks, Enterobacteriaceae, Enterobacteriaceae - drug effects, Enterobacteriaceae Infections - epidemiology, Enterobacteriaceae Infections - microbiology, ESBLs, Escherichia coli, Escherichia coli - drug effects, Escherichia coli - enzymology, Hospitalization, Humans, Infectious diseases, Klebsiella pneumoniae, Klebsiella pneumoniae - drug effects, Klebsiella pneumoniae - enzymology, Medical sciences, Microbial Sensitivity Tests, outbreaks, Pharmacology. Drug treatments, Proteus mirabilis, Proteus mirabilis - drug effects, Proteus mirabilis - enzymology, resistance, Tunisia - epidemiology, β-Lactamases